SecBot SecBot
8-K ·Filed Mar 31, 2026

VTAK

Catheter Precision, Inc.
MIXED
Impact 6/10
Horizonmonths Processed7mo ago SEC0001437749-26-010721
earnings-rerun-backfill
Actionable Insight ◆ Mixed

The acquisition of Flyte represents a significant strategic shift; monitor integration progress and future financial reporting segmentation to assess the viability of the dual-platform strategy.

DirectionMixed
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d ⚠ clustered
VTAK ▲ +3.72% at T+60d
NEUTRAL call +3.72% · α vs SPY -9.66% · entry $0.9400 → $0.9750
Entry = T+0 close
Mar 31, 2026
via day close
T+1d
-1.06%
call -1.06% · α -1.14%
$0.9300
settled 7mo ago
T+5d
+28.72%
call +28.72% · α +24.96%
$1.21
settled 7mo ago
T+20d
0.00%
call 0.00% · α -9.72%
$0.9400
settled 6mo ago
T+60d
+3.72%
call +3.72% · α -9.66%
$0.9750
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Catheter Precision reported 2025 full-year revenue of $819K, a 95% YoY increase, but posted a net loss of $17.2M. The company announced a strategic acquisition of Flyte, a regional air mobility company, marking a major pivot beyond its core medical device business.

Key Financial Metrics

EPS
−$6.65
Revenue
$819.0K
est $0.00 · +95.0% YoY
Rating
in line
Gross Margin
92.3%

Key Facts

  • 2025 full-year revenue was $819K, up 95% from $420K in 2024
  • 2025 gross margin improved to 92.3% from 90.0% in 2024
  • Net loss for 2025 was $17.2M, of which $7.8M was non-cash
  • Acquired Flyte, a technology-enabled regional air mobility company, post-year-end
  • Company will now operate across two distinct segments: Medical Devices (VIVO & LockeT) and Aviation (Flyte)

Financial Impact

Revenue increased by $399K YoY, but company remains unprofitable with a $17.2M net loss

revenuegross marginnet loss

Risk Factors

  • Company has a history of net losses and may not achieve profitability
  • Acquisition of Flyte introduces execution and integration risks in a new, unrelated industry

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-010721
Document: vtak20260329_8k.htm0001437749-26-010721
Document: 0001437749-26-010721-index-headers.html0001437749-26-010721
Document: 0001437749-26-010721-index.html0001437749-26-010721
Document: 0001437749-26-010721.txt0001437749-26-010721
8-K Data (Synthetic)0001437749-26-010721
23 reports for VTAK
Performance horizon
67% Hit rate @ T+5 4 of 6 directional calls Went positive at some point 6 of 6 best @ T+60▲ +82.93%Jun 22, 2026
Filters
Rows
Reports for VTAK — sortable, filterable
TypeNow
Oct 9, 2026
18d ago
8-K
BEARISH ★ 7/10
$1.00 $0.8200▲ +18.00%▲ +16.51%$0.6500 (+35.00%)
Oct 5, 2026
22d ago
Press Release
NEUTRAL ★ 2/10
$1.62 $1.00▼ −38.27%▼ −38.69%$0.6500 (−59.88%)
Oct 2, 2026
25d ago
8-K
NEUTRAL ★ 5/10
$1.62 $1.00▼ −38.27%▼ −38.69%$0.6500 (−59.88%)
Oct 2, 2026
25d ago
Press Release
NEUTRAL ★ 4/10
$1.62 $1.00▼ −38.27%▼ −38.69%$0.6500 (−59.88%)
Sep 28, 2026
29d ago
Press Release
NEUTRAL ★ 2/10
$0.1467awaiting T+5—$0.6500 (+343.08%)
Sep 25, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$0.1467awaiting T+5—$0.6500 (+343.08%)
Aug 27, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$0.2027 $0.1966▼ −3.01%▼ −3.28%$0.6500 (+220.67%)
Aug 11, 2026
11w ago
Press Release
NEUTRAL ★ 2/10
$0.2900 $0.2229▼ −23.14%▼ −22.73%$0.6500 (+124.14%)
Aug 4, 2026
12w ago
Press Release
NEUTRAL ★ 3/10
$0.2760 $0.2930▲ +6.16%▲ +6.26%$0.6500 (+135.51%)
Jul 13, 2026
15w ago
EFFECT
BEARISH ★ 7/10
$0.6504 $0.5020▲ +22.82%▲ +21.87%$0.6500 (+0.06%)
Showing 10 of 23

US Market Status

Market Closed — Opens Thu (9h 54m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 21, 2026